2005 | Enhanced bioavailability of piroxicam via salt formation with ethanolamines | 곽혜선 | Article |
2014 | Entecavir와 lamivudine의 간이식 후 B형 간염 바이러스 재발 예방 효과에 대한 비교 연구 | 홍주희 | Master's Thesis |
2018 | Erlotinib으로 인한 간독성 발생의 위험인자 분석 | 김민경 | Master's Thesis |
2023 | Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients | 곽혜선 | Article |
2017 | Evaluation of the predictors of readmission in Korean patients with heart failure | 곽혜선 | Article |
2018 | Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients | 곽혜선 | Article |
2018 | Factors affecting gefitinib-induced hepatotoxicity in lung cancer patients | 조소연 | Doctoral Thesis |
2019 | Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients | 한지민 | Doctoral Thesis |
2020 | Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study | 곽혜선; 한혜원; 문진영 | Article |
2018 | Factors affecting time to reach and recover from gefitinib-induced hepatotoxicity | 곽혜선; 이정연 | Article |
2020 | Factors Associated With Voriconazole Concentration in Pediatric Patients | 곽혜선; 한혜원 | Article |
2020 | Factors Associated With Voriconazole Concentration in Pediatric Patients | 곽혜선; 한혜원 | Article |
2017 | Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients | 곽혜선; 이정연 | Article |
2020 | Factors Influencing Imatinib-Induced Hepatotoxicity | 곽혜선 | Article |
2007 | Formulation and evaluation of ketorolac transdermal systems | 곽혜선 | Article |
2008 | Formulation and evaluation of ondansetron nasal delivery systems | 곽혜선 | Article |
2015 | Formulation and evaluation of resveratrol oromucosal delivery systems | 최아영 | Doctoral Thesis |
2009 | Formulation and evaluation of ubidecarenone transdermal delivery systems Ubidecarenone transdermal delivery systems | 곽혜선; 이병구 | Article |
2013 | Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems | 곽혜선 | Article |
2024 | FRAS1, FAM201A, NKX2-6 Polymorphisms and Warfarin Dose Requirements from a Genome-Wide Association Study | 김정선 | Doctoral Thesis |
2021 | Gene Polymorphisms of the Renin-Angiotensin System and Bleeding Complications of Warfarin: Genetic-Based Machine Learning Models | 곽혜선 | Article |
2020 | Genetic effects of the renin-angiotensin system on warfarin bleeding complications at therapeutic INR | 김주희 | Doctoral Thesis |
2022 | Genetic Factors of Renin–Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants | 곽혜선; 박준범; 송태진; 이정 | Article |
2019 | Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy | 곽혜선 | Article |
2020 | Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study | 곽혜선; 성종미 | Article |
2022 | Global Research Trends of Gender-Related Artificial Intelligence in Medicine Between 2001–2020: A Bibliometric Study | 곽혜선; 이정 | Article |
2020 | Health Behaviors Associated with Aggression in Korean Adolescents: Data from 2 Cross-sectional Studies | 곽혜선; 송곤진 | Article |
2018 | Impact of designated pharmacists’ interventions on physicians’ acceptance of the Knowledge-based Renal Dosage Adjustment System | 최경숙 | Doctoral Thesis |
2015 | Impact of GATA4 variants on stable warfarin doses in patients with prosthetic heart valves | 곽혜선; 정호철 | Article |
2015 | Impact of NQO1 variants on stable warfarin doses in Korean patients with mechanical cardiac valves | 곽혜선 | Meeting Abstract |